cervical dystonia,daxibotulinumtoxina for injection,revance therapeutics,clinical trial evaluating,movement disorder society,society virtual congress,duration of effect,international parkinson,phase 3,efficacy,forward-looking statements,treatment,aspen-1 clinical trial,safety of daxibotulinumtoxina